Fate Therapeutics (FATE) EBIT (2012 - 2026)
Fate Therapeutics' EBIT came in at -$31.13 million for Q2 2026, compared with -$36.97 million a year earlier.
Powered by 
Analysis
Fate Therapeutics (FATE) EBIT (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Fate Therapeutics reported EBIT of -$133.59 million; for FY2025, it came in at -$147.7 million.
- Going back by year, EBIT was -$210.28 million in FY2024, -$190.51 million in FY2023, -$308.39 million in FY2022 and -$216.99 million in FY2021.
- The Q2 2026 figure represents the highest quarterly EBIT since Q1 2023.
- Business Quant data shows FATE's EBIT at -$33 million (Q1 2026), -$34.72 million (Q4 2025) and -$34.74 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.24 Bn | 1,102.83 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 616.05 Bn | 534.58 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 500.90 Bn | 474.01 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 367.17 Bn | 321.54 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 235.77 Bn | 191.17 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 190.70 Bn | 164.90 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Fate Therapeutics | 251.63 Mn | 97.83 Mn | - | -31.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.13 Mn |
| Mar 31, 2026 | -33.00 Mn |
| Dec 31, 2025 | -34.72 Mn |
| Sep 30, 2025 | -34.74 Mn |
| Jun 30, 2025 | -36.97 Mn |
| Mar 31, 2025 | -41.28 Mn |
| Dec 31, 2024 | -61.75 Mn |
| Sep 30, 2024 | -52.38 Mn |
| Jun 30, 2024 | -45.08 Mn |
| Mar 31, 2024 | -51.07 Mn |
| Dec 31, 2023 | -48.08 Mn |
| Sep 30, 2023 | -51.28 Mn |
| Jun 30, 2023 | -62.57 Mn |
| Mar 31, 2023 | -28.59 Mn |
| Dec 31, 2022 | -64.42 Mn |
| Sep 30, 2022 | -86.39 Mn |
| Jun 30, 2022 | -83.11 Mn |
| Mar 31, 2022 | -74.47 Mn |
| Dec 31, 2021 | -69.38 Mn |
| Sep 30, 2021 | -54.62 Mn |
API Access
Fate Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();